Расширенный поиск

Хроническая обструктивная болезнь легких и сопутствующие заболевания

Полный текст:

Об авторе

А. Г. Чучалин
ФГУ НИИ пульмонологии Росздрава

Список литературы

1. Buch P., Friberg J., Scharling H. et al. Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur. Respir. J. 2003; 21 (6): 1012–1016.

2. Fuso L., Incalzi R.A., Pistelli R. et al. Predicting mortality of patients for acutely exacerbated chronic obstructive pul# monary disease. Am. J. Med. 1995; 98 (3): 272–277.

3. Kleiger R.E., Senior R.M. Long#term electrocardiographic monitoring of ambulatory patients with COPD. Chest 1974; 65: 483.

4. Shih HT., Webb C.R., Conway W.A. et al. Frequency and significance of cardiac arrhythmias in COPD. Chest 1988; 94 (1): 44–48.

5. Bittar G., Friedman H.S. The arrhythmogenicity of theo# phylline. A multivariate analysis of clinical determinants. Chest 1991; 99 (6): 1415–1420.

6. Salpeter S.R., Ormiston T.M., Salpeter E.E. Cardiovascular effects of beta – agonists in patients with asthma and COPD: a meta#analysis. Chest 2004; 125 (6): 2309–2321.

7. Incalzi R.A., Pistelli R., Cocchi A. et al. Cardiac arrhythmias and left ventricular function in respiratory failure from chronic COPD. Chest 1990; 97 (5): 1092–1097.

8. Cheong T.H., Magder S., Shapiro S. et al. Cardiac arrhyth# mias during exercise in severe chronic obstructive pul# monary disease. Chest 1990; 97 (4): 793–797.

9. Salpeter S., Ormiston T., Salpeter E. Cardioselective beta# blocker use in patients with revesible airway disease. Cochrane Database Syst. Rev. 2001; 2: CD002992.

10. Ind P.W., Dixon C.M., Fuller R.W., Barnes P.J. Anticholin# ergic blockade of beta#blocker – induced bronchoconstric# tion. Am. Rev. Respir. Dis. 1989; 139 (6): 1390–1394.

11. Behar S., Panosh A., Reicher H. et al. Prevalence and prog# nosis of COPD among 5839 consecutive patients with acute myocardial infarction. Sprint Study Group. Am. J. Med. 1992;93 (6): 637–641.

12. Man S.F. COPD as a risk factor for cardiovascular morbidi# ty and mortality. Proc. Am. Thorax Soc. 2005; 2 (1): 8–11.

13. Jousilahti P., Vartianen E., Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 1996; 348 (9027): 567–572.

14. Triboulloy C., Rosinaru D., Mahjoub H. et al. Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population – based study. Eur. Heart. J. 2008;29 (3): 339–347.

15. Dahl M., Vestbo J., Lange P. et al. C#reactive protein as a predictor of prognosis in COPD. Am. J. Respir. Crit. Care Med. 2007; 175: 250–255.

16. Schols A.M., Slangen J., Volovics L., Wouters E.F. Weight loss is a reversible factor in the prognosis of chronic obstruc# tive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998;157 (6, pt. 1): 1791–1797.

17. van Vliet M., Spruit M.A., Verleden G. et al. Hypogonadism, quadriceps, weakness, and exercise intolerance in COPD. Am. J. Respir. Crit. Care Med. 2005; 172: 1105–1111.


Для цитирования:

Чучалин А.Г. Хроническая обструктивная болезнь легких и сопутствующие заболевания. Пульмонология. 2008;(2):5-14.

For citation:

Chuchalin A.G. Chronic obstructive pulmonary disease and co-morbidities. PULMONOLOGIYA. 2008;(2):5-14. (In Russ.)

Просмотров: 224

ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)